Peter Kleist
- Endocrinology, Diabetes and Metabolism top 10%
- Molecular Biology
- Surgery
- Public Health, Environmental and Occupational Health
- Physiology
- Co-authors
- H. FuderP W LückerE StriddeBurkhard GökeR. ArnoldBernhard R. WinkelmannBernhard O. BoehmMarkus Nauck
- Topics
- Biomedical Ethics and Regulation (4 papers)Ethics in Clinical Research (4 papers)Pharmaceutical studies and practices (4 papers)
- Partner nations
- GermanySwitzerlandJapan
In The Last Decade
Peter Kleist
23 papers receiving 358 citations
Peers
Comparison fields: 5 of 96
- Endocrinology, Diabetes and Metabolism 120
- Molecular Biology 80
- Surgery 67
- Public Health, Environmental and Occupational Health 58
- Physiology 51
Countries citing papers authored by Peter Kleist
This map shows the geographic impact of Peter Kleist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kleist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kleist more than expected).
Fields of papers citing papers by Peter Kleist
This network shows the impact of papers produced by Peter Kleist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kleist. The network helps show where Peter Kleist may publish in the future.
Co-authorship network of co-authors of Peter Kleist
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kleist. A scholar is included among the top collaborators of Peter Kleist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kleist. Peter Kleist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 53 | |
| 3 | 6 | |
| 4 | 8 | |
| 5 | 16 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | 0 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 30 | |
| 13 | 6 | |
| 14 | 2 | |
| 15 | 0 | |
| 16 | 2 | |
| 17 | 14 | |
| 18 | 13 | |
| 19 | 112 | |
| 20 | Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease. | 6 |
About Peter Kleist
Peter Kleist is a scholar working on Health Informatics, Endocrinology, Diabetes and Metabolism and Toxicology, having authored 26 papers that have together received 378 indexed citations. Recurring topics across this work include Biomedical Ethics and Regulation (4 papers), Ethics in Clinical Research (4 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Health Informatics (16 citations), Endocrinology, Diabetes and Metabolism (120 citations) and Gastroenterology (21 citations). Peter Kleist has collaborated with scholars based in Germany, Switzerland and Japan. Frequent co-authors include H. Fuder, P W Lücker, E Stridde, Burkhard Göke, R. Arnold, Bernhard R. Winkelmann, Bernhard O. Boehm, Markus Nauck, Naresh Ranjith and Winfried März. Their work appears in journals such as The Lancet, Frontiers in Pharmacology and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.